Clinical Trials - AZTR

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06830863A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityRECRUITINGPHASE1, PHASE22025-08-252026-05-152026-03-15
NCT06137157Evaluation of Topical ATR12-351 in Adults With Netherton SyndromeRECRUITINGPHASE12024-06-192026-04-012026-02-01
NCT04731259Study to Evaluate the Safety of ATR-04WITHDRAWNPHASE1, PHASE22024-012026-012026-01
NCT03820076Safety Study of AZT-04 for Cosmetic UseCOMPLETEDNA2019-01-172019-07-312019-01-21